Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
Will ACA Subsidy Expiration Cause a Healthcare Crisis?
Regulatory & Compliance Will ACA Subsidy Expiration Cause a Healthcare Crisis?

As open enrollment for Affordable Care Act (ACA) plans begins, millions of Americans face uncertainty and looming price hikes, with Congress yet to decide on extending critical subsidies. To dive deeper into this pressing issue, I’m speaking with Dr. Emily Harper, a renowned healthcare policy

Unnecessary Data Burdens Clinical Trials, Study Finds
Imaging & Diagnostics Unnecessary Data Burdens Clinical Trials, Study Finds

Imagine a clinical trial where every participant must navigate a maze of assessments, travel long distances, and adjust their daily routines, only to discover that much of the information collected isn’t even essential to the study’s core goals. A recent working paper from the Tufts Center for the

Digital Health: Transforming Care and Future Innovations
Digital Health Digital Health: Transforming Care and Future Innovations

Imagine a world where a doctor’s visit is just a video call away, or where a simple wearable device on your wrist can alert you to a potential health issue before it becomes serious, transforming the way we approach healthcare. This isn’t a distant dream but the reality of digital health—a

MBI Boosts Cancer Detection in Dense Breasts with DBT
Imaging & Diagnostics MBI Boosts Cancer Detection in Dense Breasts with DBT

In the complex landscape of breast cancer screening, a significant hurdle persists for women with dense breasts, where the composition of their tissue often masks potential malignancies on traditional mammograms, heightening the risk of late-stage diagnoses. A pioneering study published in

How Is BD Transforming Pharmacy Automation with Henry Ford?
Infrastructure & Management How Is BD Transforming Pharmacy Automation with Henry Ford?

In an era where healthcare demands are skyrocketing and patient expectations for accessibility and efficiency continue to rise, the integration of cutting-edge technology in pharmacy operations has become a critical focus for health systems across the globe. A groundbreaking partnership between BD,

How Does UpToDate Expert AI Transform Healthcare Delivery?
Patient Care How Does UpToDate Expert AI Transform Healthcare Delivery?

In an era where healthcare providers face mounting pressure to deliver precise, timely care amidst overwhelming data and complex patient needs, innovative solutions are emerging to bridge critical gaps. A groundbreaking development in this space comes from Wolters Kluwer Health, a global leader in

How Is Epic Revolutionizing Healthcare Data Connections?
Digital Health How Is Epic Revolutionizing Healthcare Data Connections?

In an era where healthcare systems often grapple with fragmented data and inefficient workflows, a significant shift is underway to bridge these gaps through innovative technology. Imagine a patient seamlessly accessing their complete medical history from multiple providers in one place, or a

UMass Memorial Unveils Healing Rooftop Garden for Staff
Infrastructure & Management UMass Memorial Unveils Healing Rooftop Garden for Staff

In the heart of Worcester, Massachusetts, a remarkable transformation has taken place atop the north pavilion of UMass Memorial Medical Center, offering a much-needed sanctuary for hospital staff who navigate the relentless pressures of healthcare every day. This newly opened rooftop garden,

FDA Updates IVD Policies for Emergencies and Legal Rulings
Imaging & Diagnostics FDA Updates IVD Policies for Emergencies and Legal Rulings

In a landscape where public health crises and legal battles shape regulatory frameworks, the U.S. Food and Drug Administration (FDA) has recently made significant strides in refining its approach to in vitro diagnostic (IVD) tests. These updates come at a critical juncture, as the demand for rapid

How Will Trump’s Import Probe Affect US Medtech Stocks?
Infrastructure & Management How Will Trump’s Import Probe Affect US Medtech Stocks?

The US medical technology industry finds itself at a critical juncture as the Trump administration has rolled out a Section 232 investigation through the Department of Commerce (DOC), announced on September 25. This probe, designed to evaluate the national security risks tied to importing essential

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later